血糖採血針市場:現狀分析與預測(2022-2030年)

Blood Glucose Lancets Market: Current Analysis and Forecast (2022-2030)

出版日期: 2023年06月30日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 154 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

血糖刺血針市場保持穩定在5%左右，因為刺血針技術的進步，例如無痛超薄刺血針的開創性，顯著提高了患者的舒適度和依從性，推動市場需求預計增長。此外，擴大採用自我護理管理方法和家庭血糖監測設備也有助於市場增長。

為了更好地了解血糖採血針行業的市場介紹，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、意大利、歐洲其他地區））、亞太地區（中國、日本、歐洲其他地區）、印度、亞太地區其他地區）以及世界其他地區（基於其在各國的全球影響力）。北美在 2021 年佔據主導地位。這主要是由於久坐的生活方式、不健康的飲食習慣和遺傳傾嚮導致該地區大量人被診斷患有糖尿病。這大大增加了對糖尿病定期監測和管理的血糖採血針的需求。此外，該地區擁有發達的醫療基礎設施、對糖尿病管理的高度認識以及不斷增加的糖尿病患病率持續推動市場增長。例如，根據國際糖尿病聯盟第 10 版糖尿病圖譜，到 2021 年，美國將有大約 3220 萬人患有糖尿病，預計到 2045 年，這一數字將增至 3630 萬人。

Blood glucose lancets are small, disposable medical devices used to prick the skin and obtain a small drop of blood for glucose testing. The market for blood glucose lancets is experiencing robust growth and is expected to continue expanding in the coming years due to the rising prevalence of diabetes and obesity. For instance, the World Obesity Federation predicts that by 2030, one in five women and one in seven men will have obesity. Also, with sedentary lifestyles, unhealthy eating habits, and an aging population, the number of individuals diagnosed with diabetes has been steadily increasing. This has resulted in a higher demand for lancets used for blood glucose monitoring. Moreover, the growing awareness among patients about the significance of regular blood glucose testing for effective diabetes management has further fueled market growth.

The blood glucose lancets market is expected to grow at a steady rate of around 5% owing to the advancements in lancet technology, including the development of painless and ultra-thin lancets, which have significantly improved patient comfort and compliance, thereby driving market demand. Furthermore, the increasing adoption of self-care management approaches and home-based glucose monitoring devices has contributed to the market's growth.

Based on type, the market is segmented into push button lancet, pressure activated lancet, and side activated lancet. Among them, the push button lancet category is to witness higher CAGR during the forecast period owing to these lancets making the process of obtaining a blood sample less painful and more convenient, which has increased patient compliance with glucose testing. Also, push button lancets have made glucose testing more accessible to a wider range of individuals, including those who may have difficulty using traditional lancing devices. This has expanded the market for blood glucose lancets.

Based on end-user, the blood glucose lancets market has been bifurcated into patients/homecare and hospitals & clinics. The hospitals & clinics category is to witness higher adoption of blood glucose lancets during the forecast period. This is mainly due to the large number of diabetic patients who require blood testing kits and the rising prevalence of infectious diseases. For example, as per the International Diabetes Federation (IDF), around 1.2 million youngsters and youths have type 1 diabetes in 2021. Additionally, homecare diagnostic testing generates more revenue for the market because it is more expensive in the hospital.

For a better understanding of the market adoption of the blood glucose lancets industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America dominated the market in 2021. This is mainly due to the region having a considerable number of individuals diagnosed with diabetes, primarily due to sedentary lifestyles, unhealthy eating habits, and genetic predisposition. This has resulted in a substantial demand for blood glucose lancets for regular monitoring and management of diabetes. Additionally, the region has a well-developed healthcare infrastructure, a high level of awareness regarding diabetes management, and a growing prevalence of diabetes which will drive the growth of the market consistently. For instance, according to the International Diabetes Federation Diabetes Atlas Tenth edition, in 2021, around 32.2 million people in the United States had diabetes, projected to grow to 36.3 million by 2045.

Some of the major players operating in the market include: LifeScan IP Holdings, LLC; DarioHealth Corp; Beurer GmbH; BD; MEDISANA GMBH; Dexcom, Inc.; Abbott; AgaMatrix; Medtronic; and F. Hoffmann-La Roche Ltd.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Blood Glucose Lancets Market
2.2. Research Methodology of the Blood Glucose Lancets Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE BLOOD GLUCOSE LANCETS MARKET

6 BLOOD GLUCOSE LANCETS MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY TYPE

7.1. Push Button Lancet
7.2. Pressure Activated Lancet
7.3. Side Activated Lancet

8 MARKET INSIGHTS BY END-USER

8.1. Patients/Homecare
8.2. Hospitals & Clinics

9 MARKET INSIGHTS BY REGION

9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Rest of North America
9.2. Europe
- 9.2.1. Germany
- 9.2.2. U.K.
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Rest of Asia-Pacific
9.4. Rest of World